This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. We're so lucky to ...
A trial of a new drug regimen to treat tuberculous meningitis (TBM) has started enrolling adults and adolescents in several countries where tuberculosis (TB) is prevalent. The Improved Management with ...
Radboudumc researchers Kirsten van Abeelen, Edwin Ardiansyah, Sofiati Dian, Vinod Kumar, Reinout van Crevel and Arjan van Laarhoven used metabolomics to study cerebrospinal fluid (CSF) samples from ...
A Johns Hopkins Children's Center-led study in animals suggests that high doses of a widely used antibiotic called rifampin may safely treat and reduce the duration of treatment for the deadliest form ...
Radboudumc researchers Kirsten van Abeelen, Edwin Ardiansyah, Sofiati Dian, Vinod Kumar, Reinout van Crevel and Arjan van Laarhoven used metabolomics to study cerebrospinal fluid (CSF) samples from ...
New drugs may be needed to fight the deadliest form of tuberculosis, because it may no longer respond to current treatments. An animal study by Johns Hopkins University researchers found that an ...
Findings in animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) may not work for TB meningitis. Findings from ...
The median time to death was 13 and 24 days in the high-dose and standard-dose groups, respectively, among those who died within 6 months. (HealthDay News) — No benefit of high-dose vs standard-dose ...
Malaysians have been urged to stay vigilant. Follow us on Instagram , TikTok, and WhatsApp for the latest stories and ...
Adjunctive corticosteroids may reduce mortality from all forms of tuberculosis by 17%, no matter which organ group was affected, according to a meta-analysis. Julia A. Critchley, DPhil, from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results